“If this blog helped you out, don’t keep it to yourself—share the link on your socials!” 👍 “Like what you read? Spread the love and share this blog on your social media.” 👍 “Found this useful? Hit share and let your friends know too!” 👍 “If you enjoyed this post, please share the URL with your friends online.” 👍 “Sharing is caring—drop this link on your social media if it helped you.”

Sunday, August 31, 2025

Cubist Pharmaceuticals


Cubist Pharmaceuticals products


C

  • Cubicin® — daptomycin for injection

    • Indication: Once-daily intravenous antibiotic for serious Gram-positive infections such as MRSA bacteremia and complicated skin and skin structure infections.

D

  • Dificid® — fidaxomicin

    • Indication: Treatment of Clostridioides difficile-associated diarrhea (CDAD).

E

  • Entereg® — alvimopan

    • Indication: Accelerates gastrointestinal recovery following partial bowel resection surgery with primary anastomosis.

S

  • Sivextro® — tedizolid phosphate

    • Indication: Treatment of acute bacterial skin and skin structure infections (ABSSSI), including MRSA.

Z

  • Zerbaxa® — ceftolozane/tazobactam

    • Indication: Combination antibiotic for complicated intra-abdominal infections (when paired with metronidazole) and complicated urinary tract infections.




on

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)